The Global market of Pain Management Drugs is projected to display a robust growth represented by a CAGR of 4.96% during 2016– 2021F

Date: 4 May 2017

Over the recent years, the global drug pain management industry has been growing rapidly as the global sales of drugs which are used for the treatment of chronic pain conditions of neck, lower back, shoulders, post-operative pain, and pain during the sports injuries. Globally, the growth in the drug pain management market is driven by large number of chronically ill patients, rise in global incidences of cancer and strong presence of pipeline drugs used for chronically ill conditions. 

According to Azoth Analytics research report “GlobalPain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine,Anticonvulsants), By Application, By Region, By Country: Opportunities andForecast (2011-21)", global market is projected to display a robust growth represented by a CAGR of 4.96% during 2016– 2021F, chiefly driven by large number of drugs in pipeline, rising number of chronically ill patients, new reforms and regulations in the consumption of medical cannabis.

Globally, only opioids are gaining the maximum market share. Medical opioids basically fall under categories of low efficacy opioids, moderate opioids, and high efficacy opioids. Examples of strong opioids are morphine and pethidine. They are effective against severe pain and are mostly administered by injection. Moderate efficacy opioids include dihydrocodeine (e.g. DF118), tilidine (DF118n) and tramadol (Tramal). They are effective against moderate pain, and in adequate doses also against more severe pain. They can be taken orally. Tramadol causes less sedation and respiratory depression. Low-efficacy opioids examples include codeine (codeine phosphate).They are effective against mild to moderate pain. Companies have been strategically expanding their market through multiple licensing in terms of manufacturing, sales and marketing of 
Medical opioids. 

Among the applications, oncology will witness faster growth whereas among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in chronically ill patients and increase consumption of medical opioids.

The report titled “GlobalPain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine,Anticonvulsants), By Application, By Region, By Country: Opportunities andForecast (2011-21)”, has covered and analysed the potential of Global Drug Pain Management Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Drug Pain Management Market on the basis of Analysis By Drug Type (Opioids, NSAIDS, Anti-migraine, Anti-convulsants), Pipeline Analysis, By Region (North America, Europe, APAC, Latin America and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Brazil and Mexico).
...